Physician profile
Tracey Agnese
NPI 1891929584
$1,354.78
in general payments reported to CMS, 2019-2025
18 companies · $111 in 2025
The $111 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $92.09 · 2021: $283 · 2022: $184 · 2023: $209 · 2024: $57.71 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $392.38 | 2019-2024 | Bexsero, Pediarix |
| Kaleo, INC. | $223.88 | 2019-2022 | |
| Genentech USA, INC. | $138.59 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $114.87 | 2019-2025 | Vaxneuvance, Gardasil 9, M-M-R II |
| Antares Pharma, INC. | $70.15 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.40 | 2021 | |
| Sanofi Pasteur INC. | $51.36 | 2019-2023 | |
| Amgen INC. | $50.97 | 2020-2021 | |
| Hologic Sales and Service, LLC | $42.80 | 2025 | Aptima |
| Cranial Technologies, INC | $33.24 | 2021 | |
| Abbott Laboratories | $27.63 | 2025 | Id Now Instrument |
| Corium, LLC | $26.29 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.94 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $24.78 | 2021 | |
| Alexion Pharmaceuticals, INC. | $20.76 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $19.70 | 2025 | Ycanth |
| Welch Allyn | $19.60 | 2021 | |
| Ironshore Pharmaceuticals INC. | $19.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Agnese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.